In the current climate of American health care reform, effective and accurate performance measurement and reporting of the quality of care provided by caregivers have risen to the top of critical priorities. On one hand, there are more than 100 regional quality reporting initiatives relying on public reporting of performance measures, and yet there is a high degree of variability as to which of these measures are reported, compared, and implemented. 1 Certainly, the increased availability of comparative clinical outcomes among providers of care has proven to be an initial effective catalyst in achieving significant improvements and transparency in the quality of care delivered within the US health system, 2 but high-quality evidence of significant overall impact is still lacking. 3 As a result of these documented inconsistencies, in the current issue of this journal, Roski and Kim have correctly called for a more efficient means of generating nationally consistent performance information. 1 Indeed, the Quality Alliance Steering Committee has already developed a road map and 3-year plan to establish a cohesive infrastructure to achieve this very important national goal. 4 Given the growing mandate for health care providers to demonstrate meaningful improvements in clinical quality, the effective implementation of evidence-based performance measures that are derived from well-constructed clinical practice guidelines has become a critical success factor. When developed by professional society and other health care delivery experts, such guidelines and measures must also ensure both feasibility and improved outcomes, especially to the public and payers. To the extent that core performance measures can be adopted uniformly across the spectrum of payers, individual practitioners and groups will be able to implement delivery schemes more effectively. 5 Because the stakes have become higher than ever to achieve these ends, a more rigorous and consistent approach to these complex issues, such as outlined in the following discussion, must now be established.
Clinical practice guidelines require a systematic evaluation of evidence behind the science supporting guideline recommendations for care delivery. Using a taxonomy or framework for grading the quality of evidence and providing a subsequent concomitant "strength of recommendation" is desirable whenever possible. This framework should be published along with guideline recommendations and supporting text, which should also include a summary of the quality of the evidence using graphical and tabular summary statistical techniques. Examples include the evidence grade definitions used by the US Preventive Services Task Force, 6 the modified Grading of Recommendations Assessment, Development and Evaluation (GRADE) system 7 used by the American College of Physicians Clinical Effectiveness Assessment Subcommittee, 8 and the system deployed by the American College of Cardiology and American Heart Association. 9 Another excellent example is the evidence grading system deployed by the Society for Healthcare Epidemiology of America to reduce hospitalacquired infections, 10 but currently, there is no standard "one size fits all" approach to be used by every group of guideline developers.
Performance measures should be based on clinical practice guidelines and are useful to assess whether care delivery is achieved in accordance with guideline recommendations. There are 5 critical aspects of performance measures with respect to scientific evidence.
First, any performance measure should be developed and accompanied by a structured evaluation of evidence such as those already mentioned for clinical practice guidelines. The most useful and valid performance measures are those that are based on both the highest quality of evidence and the strongest recommendations from guideline developers. Under these circumstances, it is more likely that well-constructed performance measures will actually evaluate the degree to which quality of care has been delivered. Subsequent quality improvement methods and initiatives designed to increase the frequency of care in accordance with higher success of such measures will also be more likely to have a significant impact on the target population.
Second, certain performance measures can be independently evaluated as to whether actual improvements in care can be achieved if levels of performance increase. Such an evaluation will, over time, generate a second type of evidence that can also be systematically assessed using quasiscientific or qualitative methods. This step is of critical importance to further determine feasibility, importance, and validity and also subsequent meaningful refinements to a given performance measure. Currently, no standardized methods are available to achieve this important goal other than traditional statistical and epidemiological techniques. Perhaps a specific assessment of successful implementation of performance measures should be developed to permit a more consistent, effective approach to demonstrating meaningful quality improvements.
Third, performance measures that assess the delivery of a process of care and/or the care delivery system structures within which the process of care is delivered should be assessed as to whether or not the desired improvement in outcome for the target population is actually achieved. The most ideal performance measures are those that link evidence that combines what is already published in practice guidelines with the actual experience of the end users to a measurable and "real-world" improvement in quality of care. Here, again, more traditional statistical and epidemiological techniques may not be useful to evaluate this phenomenon; hence newer methods must be developed.
Fourth, performance measures that can be combined into "composite measures" are useful to facilitate an aggregate evaluation of care delivery for a given condition and/or population. However, combining different types of performance measures (eg, those measuring structure, process, and outcome) can be often challenging for several reasons. A "measure set" of care processes and associated outcomes for a given condition may contain performance measures with varying levels of evidence and strength of recommendations from the reference practice guidelines. More often, there are no standard evidence and recommendation taxonomies to apply to this type of composite measure set, thereby confounding any multivariate assessment as to which components of the composite measure will predict the biggest effect on overall improvement, especially outcomes.
In some cases, a composite measure may evaluate something much larger than the individual measures within it (eg, the overall effectiveness of the underlying system of care that delivers the individual services). An excellent example of this concept is the Centers for Medicare and Medicaid Services (CMS)-Premier Hospital Quality Improvement Demonstration Project 11 that provided financial rewards to a number of hospitals that achieved high levels of performance on a series of composite measures for Medicare patients with acute myocardial infarction, community-acquired pneumonia, heart failure, and high-cost surgical procedures.
Fifth and most important is that any future performance measures (or composite measures) that are to be used for public reporting and/or monetary incentives (especially pay for performance) must be presented in a clear and readily transparent fashion. Such public reports must be accompanied by the systematic summary of the evidence obtained from the associated practice guideline and, if available, the additional evidence evaluation of the performance measures. The National Quality Forum has developed such an initial rudimentary framework, but much more work is needed in this area.
The "end users" of these performance measures (eg, CMS, The Joint Commission, Leapfrog, state quality reporting systems) should hence always openly acknowledge, in a direct and easily understood format, the evidence evaluation accompanying any given performance measure used for accountability. Merely providing a bibliography of references or summaries of expert opinion must not be deemed true "evidence" in this regard. Such transparency must also be consistently extended to purchasers, providers, andmost important-patients, so that misleading information and expectations do not lead to misperception, confusion and conflict. Attempting to simplify complex issues with symbolic representations and statistical comparisons that are not clinically meaningful or mathematically accurate should also be avoided at all costs.
Significant education of all stakeholders is now of critical importance to the issues outlined by Roski and Kim as well as those in this editorial. More important is the need to develop more consistent and comprehensive methods of performance measurement development and implementation in accordance with practice guidelines that are based on sound evaluation and grading of scientific evidence. Such a disciplined and standardized approach to improving the quality of care delivered by public and private health systems, physicians, and other health professionals is now of paramount importance in the high stakes of US health care reform.
